[Development and prognosis of Duhring-Brocq disease in aged patients. Apropos of 16 cases].
D000367:Age Factors; D000368:Aged; D003348:Cortisone / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000150:complications; D011379:Prognosis; D013449:Sulfonamides / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D013449:Sulfonamides; D003348:Cortisone
Evolution et pronostic de la maladie de Duhring-Brocq du sujet âgé. A propos de 16 observations.